Min Fang
Directeur/Bestuurslid bij JINXIN FERTILITY GROUP LIMITED
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Aleksandrs Zhavoronkov | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014.
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 10 jaar |
Yiwen Zhu | M | 60 | 15 jaar | |
Feng Ren | M | 49 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 3 jaar |
Ren Feng | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | - |
Aleksandr Aliper | M | 34 |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014.
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 10 jaar |
Yong Zhong | M | 52 | 6 jaar | |
Yang Dong | M | 37 | 6 jaar | |
Jun Wang | F | 37 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 4 jaar |
Roman Kyrychynskyi | M | 48 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 1 jaar |
Denitsa Milanova | M | 39 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 1 jaar |
Steven Kenneth Galson | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | - |
Yang Yang Zhai | F | - | 5 jaar | |
Li Hong Geng | M | 55 | 4 jaar | |
Kan Chen | M | 42 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong.
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | 3 jaar |
Hanmei Huang | M | - | 4 jaar | |
Xiao Qing Yan | F | 54 | 6 jaar | |
Yi Jiang Zhuang | M | 60 | 5 jaar | |
Rong Lyu | F | 43 | 3 jaar | |
Min Fang | M | 45 |
Stanford University
| 8 jaar |
Jian Wei Li | M | 51 | 3 jaar | |
Chang Qing Ye | M | 53 | 5 jaar | |
Xiao Bo Wang | M | 49 | 5 jaar | |
Jing Song Wang | M | 60 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 1 jaar |
Evgeny Izumchenko | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | 9 jaar |
Evelyne Bischof | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | 5 jaar |
Sau Mei Ng | F | 47 | 3 jaar | |
Sujata Rao | M | 64 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 2 jaar |
Kwok Yin Lau | M | 39 | 3 jaar | |
John Wilcox | M | 61 | 6 jaar | |
Hong Mei Duan | F | 45 | 2 jaar | |
Frank M. Longo | M | - |
Stanford University
| 18 jaar |
Yuan Li | M | 53 | 3 jaar | |
Kan Chen | - | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | - |
Zhe Hu | F | 50 | 6 jaar | |
Jennifer Cochran | M | 52 |
Stanford University
| 19 jaar |
Garri Zmudze | M | - |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | 8 jaar |
Ming Zi Chen | M | 54 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 3 jaar |
Stefan Heller | M | 58 |
Stanford University
| 19 jaar |
Fred M. Gibbons | M | 75 |
Stanford University
| 18 jaar |
Meixi Deng | F | 51 | 5 jaar | |
Ling Chi | M | 69 | 6 jaar | |
Kwan Wai Leung | F | 43 |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | 1 jaar |
Paul Stuart Auerbach | M | 72 |
Stanford University
| 19 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Hesaam Esfandyarpour | M | - |
Stanford University
| 5 jaar |
Aparna Sinha | M | - |
Stanford University
| - |
Styrmir Sigurjonsson | M | 50 |
Stanford University
| 7 jaar |
Wang Bin | M | 59 | - | |
Helmy Eltoukhy | M | 45 |
Stanford University
| 9 jaar |
Charles H. House | M | 83 |
Stanford University
| - |
Ying Zhong | M | 66 | 4 jaar | |
Iveshu Bhatia | M | - |
Stanford University
| 1 jaar |
Geoffrey Woo | M | - |
Stanford University
| 4 jaar |
Joel Dudley | M | - |
Stanford University
| 4 jaar |
Adam Klotz | M | - |
Stanford University
| 10 jaar |
Etosha Cave | M | - |
Stanford University
| 8 jaar |
Kathy Hannun | F | - |
Stanford University
| 10 jaar |
Ben Daniel | M | - |
Stanford University
| 1 jaar |
Eric Bahn | M | - |
Stanford University
| 5 jaar |
Elaine Zelby | F | - |
Stanford University
| 5 jaar |
Zavain Dar | M | 35 |
Stanford University
| 6 jaar |
Greg Kress | M | - |
Stanford University
| 5 jaar |
Haomiao Huang | M | - |
Stanford University
| 7 jaar |
Neel Murthy | M | - |
Stanford University
| 6 jaar |
Wesley Lim | M | - |
Stanford University
| 4 jaar |
Brain Banwoong Koo | M | - |
Stanford University
| 2 jaar |
Nabeel Hasnain | M | - |
Stanford University
| 4 jaar |
Erin Yang | F | - |
Stanford University
| 5 jaar |
Forrest White | M | - |
Stanford University
| 5 jaar |
Zheng Su | F | - |
Stanford University
| 4 jaar |
Andreas Eckner | M | - |
Stanford University
| 4 jaar |
Jung-il Choi | M | - |
Stanford University
| 6 jaar |
Chase Beeler | M | - |
Stanford University
| 5 jaar |
Hugh Browne | M | - |
Stanford University
| 2 jaar |
Elizabeth Xie | M | - |
Stanford University
| 6 jaar |
Emily Melton | F | - |
Stanford University
| 10 jaar |
Manu Kumar | M | - |
Stanford University
| 5 jaar |
Elvina Mintarno | F | - |
Stanford University
| 4 jaar |
Ali Jamal | M | - |
Stanford University
| 5 jaar |
Andrew Gustin | M | - |
Stanford University
| 9 jaar |
Elizabeth Weil | F | - |
Stanford University
| 6 jaar |
Gee-Liek Yeo | M | - |
Stanford University
| 6 jaar |
Rapp Alyssa | F | 45 |
Stanford University
| 2 jaar |
Curtis Spencer | M | - |
Stanford University
| - |
Manu Lakkur | M | - |
Stanford University
| 5 jaar |
Mike Rothenberg | M | - |
Stanford University
| 5 jaar |
Alex W. Bergman | M | - |
Stanford University
| 2 jaar |
John Melas-Kyriazi | M | - |
Stanford University
| 4 jaar |
Stephen D. Klein | M | - |
Stanford University
| 5 jaar |
John Komkov | M | - |
Stanford University
| 10 jaar |
Haw-Kuang Lim | M | 70 | 2 jaar | |
James P. McGillicuddy | M | - |
Stanford University
| 5 jaar |
Michael Paulus | M | - |
Stanford University
| 5 jaar |
Nick Noone | M | - |
Stanford University
| 4 jaar |
Kunal Ghosh | M | - |
Stanford University
| 5 jaar |
Karen Martell | F | - |
Stanford University
| 4 jaar |
Dmitry Pushkarev | M | - |
Stanford University
| 5 jaar |
Samir Siddhanti | M | - |
Stanford University
| 5 jaar |
Mada Seghete | F | - |
Stanford University
| 8 jaar |
Guillaume Horel | M | - |
Stanford University
| 4 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 68 | 68.69% |
Kaaimaneilanden | 33 | 33.33% |
Hongkong | 2 | 2.02% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties